Predictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves’ Hyperthyroidism: The RISG Study

Figure 1

Flow chart of the inclusion process comprising the two substudies RISG1 (predictor of attaining remission) and RISG2 (comparing relapse rates in patients randomized to observation or fixed low dose antithyroid drug treatment; FLATD).